These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 13468313)

  • 1. [Modifications of catalase activity in the blood and liver punctates in cancer and precancer of the stomach; preliminary communication].
    BRAMBERGA VM
    Vopr Klin Lecheniia Zlokachestvennykh Novoobraz; 1956; 4():205-7. PubMed ID: 13468313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver catalase and liver non-hemin iron in gastric cancer].
    SASORI T
    Gan; 1956 Dec; 47(3-4):294-5. PubMed ID: 13415007
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic substances in cancer. IV. On a factor in gastric carcinoma tissue inhibiting the catalase activity of the mouse liver.
    OH-UTI K; SATO J; ABE H
    Tohoku J Exp Med; 1957 Dec; 67(1):97-103. PubMed ID: 13529967
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood catalase characteristics in patients with stomach cancer].
    Komov VP; Rakhmanina TF; Drukin EIa
    Vopr Onkol; 1973; 19(10):46-50. PubMed ID: 4788588
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver catalase activity of patients with gastric cancer.
    OH-UTI K; MAKI K; ITO J; ANEHA Y; KOYAMA T
    Tohoku J Exp Med; 1958 Feb; 67(2-3):159-61. PubMed ID: 13556764
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver catalase activity in gastric cancer patients, in relation to the classified types of gastric carcinoma and pathological changes of liver.
    HISHIKAWA S
    Gan; 1959 Sep; 50():309-20. PubMed ID: 14402033
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical studies on liver catalase activity gastric carcinoma cases. II. Experimental supplements.
    YAMAGUCHI I
    Tohoku J Exp Med; 1959 Sep; 70():305-10. PubMed ID: 13846393
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pigment function of the liver in patients with stomach cancer before and after surgical intervention].
    Lepp EK
    Sov Zdravookhr Kirg; 1965; 2():38-40. PubMed ID: 5840207
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical studies on liver catalase activity in gastric carcinoma cases. I. Clinical observations.
    YAMAGUCHI I
    Tohoku J Exp Med; 1959 Aug; 70():291-304. PubMed ID: 13846394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contributions to the problem of toxohormone. II. Catalase of blood draining from gastric tumors].
    Frangini G
    Osp Ital Chir; 1965; 12(5):535-9. PubMed ID: 5840572
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic disorders in the liver after the preoperative irradiation of stomach cancer].
    Berdov BA; D'iakova AM; Stefani NV; Senokosov NI
    Med Radiol (Mosk); 1980 Aug; 25(8):29-32. PubMed ID: 7401971
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on a factor in human gastric carcinoma tissue inhibiting the catalase activity of the mouse liver].
    YAMAGUCHI I; SATO J; ABE H
    Gan; 1957 Dec; 48(4):596-8. PubMed ID: 13524523
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antioxidant status of patients with primary colorectal cancer and liver metastases of colorectal cancer].
    Czeczot H; Skrzycki M; Podsiad M; Gawryszewska E; Nyckowski P; Porembska Z
    Pol Merkur Lekarski; 2005 Jan; 18(103):58-61. PubMed ID: 15859549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the relation of the types of gastric cancer to liver catalase activity, and histochemical change in the liver].
    AIZAWA S; TOMITA K; MATUDA K; HISHIKAWA S
    Gan; 1955 Sep; 46(2-3):107-8. PubMed ID: 13262290
    [No Abstract]   [Full Text] [Related]  

  • 15. Copper metabolism in the liver in gastric cancer.
    IIJIMA N; MATSUURA K; FUJITA K; AIBA T; UKISHIMA H
    Gan; 1959 Mar; 50(1):77-87. PubMed ID: 13640137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution to the study of catalase in the blood of cancer patients].
    CERVIGNI T
    Boll Soc Ital Biol Sper; 1953; 29(9-10-11):1751-4. PubMed ID: 13140702
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid peroxidation and antioxidant status in stomach cancer.
    Batcioglu K; Mehmet N; Ozturk IC; Yilmaz M; Aydogdu N; Erguvan R; Uyumlu B; Genc M; Karagozler AA
    Cancer Invest; 2006 Feb; 24(1):18-21. PubMed ID: 16466987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of inhibiting properties of rat liver catalase in the blood plasma of cancerous and non-cancerous subjects].
    PLAZA DE LOS REYES M; MARTENS J; QUAPPE G
    Rev Med Chil; 1953 Nov; 81(11):679-83. PubMed ID: 13156133
    [No Abstract]   [Full Text] [Related]  

  • 19. Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer.
    Moon YW; Rha SY; Zhang X; Jeung HC; Yang WI; Kwon O; Jeong JH; Cheon SH; Yoo NC; Chung HC
    J Surg Oncol; 2009 Nov; 100(6):459-65. PubMed ID: 19598149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of antioxidant status in patients with primary hepatocellular carcinoma].
    Czeczot H; Skrzycki M; Gawryszewska E; Podsiad M; Porembska Z
    Pol Merkur Lekarski; 2003 Aug; 15(86):118-22. PubMed ID: 14648972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.